141 related articles for article (PubMed ID: 19697622)
21. Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis.
Ch'ng ES; Tuan Sharif SE; Jaafar H
Asian Pac J Cancer Prev; 2012; 13(9):4445-52. PubMed ID: 23167359
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis in breast cancer is related to age but not to other prognostic parameters.
Marinho A; Soares R; Ferro J; Lacerda M; Schmitt FC
Pathol Res Pract; 1997; 193(4):267-73. PubMed ID: 9258952
[TBL] [Abstract][Full Text] [Related]
23. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases.
Aranda FI; Laforga JB
Pathol Res Pract; 1996 Feb; 192(2):124-9. PubMed ID: 8692712
[TBL] [Abstract][Full Text] [Related]
24. Correlation of microvessel parameters in invasive ductal carcinoma of the breast and fibroadenomas: a morphometric study.
Boruah D; Bhatia JK; Rai A; Srinivas V; Nijhawan VS
Ann Diagn Pathol; 2016 Dec; 25():72-78. PubMed ID: 27806851
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.
Cheng SH; Liu JM; Liu QY; Luo DY; Liao BH; Li H; Wang KJ
Int J Clin Exp Pathol; 2014; 7(9):5855-63. PubMed ID: 25337227
[TBL] [Abstract][Full Text] [Related]
26. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
[TBL] [Abstract][Full Text] [Related]
27. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?
Goulding H; Abdul Rashid NF; Robertson JF; Bell JA; Elston CW; Blamey RW; Ellis IO
Hum Pathol; 1995 Nov; 26(11):1196-200. PubMed ID: 7590692
[TBL] [Abstract][Full Text] [Related]
28. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
29. Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIII-related antigen" (von Willebrand factor) expression in tumor microvessels.
Mahzouni P; Mohammadizadeh F; Mougouei K; Moghaddam NA; Chehrei A; Mesbah A
Indian J Pathol Microbiol; 2010; 53(4):605-10. PubMed ID: 21045378
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours.
Kuzu I; Bicknell R; Harris AL; Jones M; Gatter KC; Mason DY
J Clin Pathol; 1992 Feb; 45(2):143-8. PubMed ID: 1371777
[TBL] [Abstract][Full Text] [Related]
32. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.
Weind KL; Maier CF; Rutt BK; Moussa M
Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579
[TBL] [Abstract][Full Text] [Related]
33. Relationship between staining by digital subtraction angiography and vascularity in breast cancer: analysis of the time-density curve and the results of staining for factor VIII-related antigen/von Willebrand factor.
Watanabe O; Haga S; Shimizu T; Imamura H; Kobayashi K; Kinoshita J; Kajiwara T; Fujibayashi M
Breast Cancer Res Treat; 1995 Mar; 33(3):269-73. PubMed ID: 7538358
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
36. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.
Vermeulen PB; Verhoeven D; Fierens H; Hubens G; Goovaerts G; Van Marck E; De Bruijn EA; Van Oosterom AT; Dirix LY
Br J Cancer; 1995 Feb; 71(2):340-3. PubMed ID: 7530985
[TBL] [Abstract][Full Text] [Related]
37. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer.
Tomisaki S; Ohno S; Ichiyoshi Y; Kuwano H; Maehara Y; Sugimachi K
Cancer; 1996 Apr; 77(8 Suppl):1722-8. PubMed ID: 8608569
[TBL] [Abstract][Full Text] [Related]
38. Correlation between Contrast-Enhanced Ultrasound and Microvessel Density via CD31 and CD34 in a rabbit VX2 lung peripheral tumor model.
Xing J; He W; Ding YW; Li Y; Li YD
Med Ultrason; 2018 Feb; 1(1):37-42. PubMed ID: 29400366
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast.
Teo NB; Shoker BS; Jarvis C; Martin L; Sloane JP; Holcombe C
Eur J Cancer; 2003 Jan; 39(1):38-44. PubMed ID: 12504656
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle.
Zhang EG; Smith SK; Charnock-Jones DS
Reproduction; 2002 Nov; 124(5):703-11. PubMed ID: 12417009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
